COMMITMENTS AND CONTINGENCIES (Details) - USD ($) |
3 Months Ended | |
|---|---|---|
Mar. 31, 2022 |
Oct. 24, 2020 |
|
| COMMITMENTS AND CONTINGENCIES | ||
| Deferred underwriting commissions | $ 11,697,550 | |
| Over allotment | ||
| COMMITMENTS AND CONTINGENCIES | ||
| Underwriting option period | 45 days | |
| Number of units granted to underwriters | 4,500,000 | |
| Shares issued underwriters | 3,421,570 | |
| Issue price per share | $ 0.35 | |
| Number of units expired and unexercised | 1,078,430 |
| X | ||||||||||
- Definition Amount of unrecognized fee revenue received from underwriting that is deferred. No definition available.
|
| X | ||||||||||
- Definition Represents the number of shares expired and unexercised No definition available.
|
| X | ||||||||||
- Definition Represents the number of units granted to the underwriters. No definition available.
|
| X | ||||||||||
- Definition The underwriting option period. No definition available.
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|